Lv5
1370 积分 2022-11-17 加入
中国强迫症防治指南2016（精编版）
1天前
已完结
以二甲双胍为基础的固定复方制剂治疗 2型糖尿病专家共识
5天前
已完结
恩格列净/二甲双胍复方制剂临床应用专家指导意见
6天前
已完结
A National, Multi-Center, Prospective Study Evaluating the Long-Term Safety and Effectiveness of Roxadustat for Anemia Treatment in Patients with CKD (ROXSTAR Registry)
19天前
已关闭
A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study
20天前
已完结
Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan
22天前
已完结
Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study
22天前
已完结
Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
1个月前
已完结
Cardiorenal outcomes with dapagliflozin by baseline glucose-lowering agents: Post hoc analyses from DECLARE-TIMI 58
1个月前
已完结
Sodium-glucose co-transporter-2 inhibitors with and without metformin: A meta-analysis of cardiovascular, kidney and mortality outcomes
1个月前
已完结
皖公网安备34019202002308
